Project activities
Overview
Generic drugs play a crucial role in affordable healthcare, but development can be lengthy and costly due to regulatory requirements and formulation challenges. This project harnesses AI and machine learning to streamline development, accelerate timelines and reduce costs.
Discuss this projectObjectives
- Develop AI models to optimize drug formulation processes
- Use machine learning to predict and mitigate regulatory hurdles
- Enhance the efficiency of bioequivalence studies through AI
- Integrate AI tools into existing drug development workflows
- Conduct pilot studies to validate AI-enhanced processes
- Share findings and best practices with the pharmaceutical industry
Methodology
- Gather comprehensive datasets from existing generic drug development projects
- Develop AI and machine learning models to optimize formulation and predict regulatory challenges
- Integrate AI tools with pharmaceutical company workflows
- Conduct controlled pilot trials to test and refine processes
- Analyze data to assess improvements in development time, cost and regulatory success
- Disseminate results through publications, workshops and conferences
Beneficiaries
- Patients — improved access to affordable medications
- Pharmaceutical companies — reduced development costs and time to market
- Regulatory agencies — more predictable approval outcomes
- Healthcare providers — greater availability of cost-effective treatments
- Insurance companies — lower drug costs and increased savings
- Policy makers — data-driven insights for healthcare regulation